PharmaResearch Co., Ltd. (KOSDAQ:214450)

South Korea flag South Korea · Delayed Price · Currency is KRW
328,500
-21,000 (-6.01%)
Mar 3, 2026, 3:30 PM KST
11.73%
Market Cap 3.63T
Revenue (ttm) 496.03B
Net Income (ttm) 151.24B
Shares Out 10.39M
EPS (ttm) 14,523.95
PE Ratio 24.06
Forward PE 17.85
Dividend 1,100.00 (0.31%)
Ex-Dividend Date Dec 29, 2025
Volume 138,848
Average Volume 243,253
Open 342,000
Previous Close 349,500
Day's Range 327,500 - 347,500
52-Week Range 289,500 - 713,000
Beta 0.63
RSI 39.47
Earnings Date Feb 4, 2026

About PharmaResearch

PharmaResearch Co., Ltd., together with its subsidiaries, operates as a biopharmaceutical company primarily in South Korea. The company offers Re-An eye drops for protecting eyes from corneal damages with various causes; JBP PLAMON injection, a brown ampoule containing a pale yellow transparent liquid; ZADAXIN injection, an adjunctive therapy for influenza vaccination in immunocompromised elderly patients; PLACENTEX injection for the treatment and tissue restoration of wounds; CLEVIEL VOLUME to temporarily improve facial wrinkles in adults thro... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1993
Employees 497
Stock Exchange KOSDAQ
Ticker Symbol 214450
Full Company Profile

Financial Performance

In 2024, PharmaResearch's revenue was 350.12 billion, an increase of 34.14% compared to the previous year's 261.01 billion. Earnings were 92.04 billion, an increase of 20.24%.

Financial Statements

News

There is no news available yet.